Page last updated: 2024-10-26

brl 42810 and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

brl 42810 has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies

Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.

Research Excerpts

ExcerptRelevanceReference
"We described two chronic hepatitis B carriers (both hepatitis B e antigen negative), who cleared HBsAg after allogeneic bone marrow transplantation."1.30Histological changes during clearance of chronic hepatitis B virus infection by adoptive immunity transfer. ( Au, WY; Lau, GK; Liang, R; Wu, PC; Yuen, ST, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lau, GK1
Yuen, ST1
Au, WY1
Wu, PC1
Liang, R1

Other Studies

1 other study available for brl 42810 and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
Histological changes during clearance of chronic hepatitis B virus infection by adoptive immunity transfer.
    Journal of gastroenterology and hepatology, 1999, Volume: 14, Issue:3

    Topics: 2-Aminopurine; Adolescent; Adult; Antiviral Agents; Bone Marrow Transplantation; Famciclovir; Hepati

1999